ANN ARBOR, Mich., March 07, 2018 -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM), a veterinary diagnostic and pharmaceutical company, today announced that it will present at the 30th Annual ROTH Conference on March 13, 2018 in Dana Point, CA.
Chief Executive Officer Gerald Solensky, Jr. will provide an overview of Zomedica’s business during his live presentation and will be available to participate in one-on-one meetings with investors registered to attend the conference.
30th Annual ROTH Conference
Date: Tuesday, March 13, 2018
Time: 2:30 p.m. PDT
Location: The Ritz-Carlton Laguna Nigel, Dana Point, CA
Investors and other interested parties will be able to access a live webcast of the presentation by visiting Zomedica’s website at http://investors.zomedica.com. A replay of the webcast will be accessible on the Zomedica website following the event.
About Zomedica
Based in Ann Arbor, Michigan, Zomedica (NYSE American:ZOM) (TSX-V:ZOM) is a veterinary diagnostic and pharmaceutical and company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. Zomedica’s product portfolio will include novel diagnostics and innovative therapeutics that emphasize patient health and practice health. With a team that includes clinical veterinary professionals, it is Zomedica’s mission to give veterinarians the opportunity to lower costs, increase productivity, and grow revenue while better serving the animals in their care. For more information, visit www.ZOMEDICA.com.
Follow Zomedica
- Email Alerts: http://investors.zomedica.com
- LinkedIn: https://www.linkedin.com/company/zomedica
- Facebook: https://www.facebook.com/zomedica/
- Twitter: https://twitter.com/zomedica
Reader Advisory
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of the release.
Investor Relations Contacts
Shameze Rampertab, CPA, CA
[email protected]
+1 647.283.3630
PCG Advisory Group
Kirin Smith, COO
[email protected]
+1 646.863.6519
www.pcgadvisory.com
Media Contact
Andrea Eberle
[email protected]
+1 734.369.2555


Daimler Truck Q2 Profit Falls 18%, 2026 Outlook Raised
Cloudflare Stock Jumps 15% as Earnings Beat Estimates, 2026 Outlook Raised
Infineon Raises 2026 Revenue Outlook as AI Data Center Demand Fuels Record Quarterly Sales
DeepSeek to Raise AI API Prices as Demand for New Models Surges
Meta Ordered to Pay $567M Over Child Safety Violations in New Mexico
Nvidia to Invest Up to $3 Billion in Blackstone-Backed Lancium
AMP Shares Surge 13% After Strong Profit and A$150 Million Buyback
UK AI Security Tests Reveal Anthropic and OpenAI Agents Attempted Unauthorized Actions
DHL Q2 Profit Jumps 24% as Express Business Drives Growth
Siemens Energy Q3 Profit Beats Forecast as AI-Driven Power Demand Fuels Growth
Western Digital Q4 Earnings Beat Estimates as FY2027 Outlook Tops Expectations
Heineken H1 Operating Profit Meets Forecast as Beer Volumes Beat Expectations
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
Sinopec Boosts Russian ESPO Oil Purchases as Middle East Supply Tightens
UOB Q2 Net Profit Rises 10% as Wealth Management Growth Boosts Earnings
Glencore Posts Strong H1 2026 Earnings, Announces ASX Secondary Listing
SoftBank Q1 Profit Beats Forecast as Intel Rally and OpenAI Investments Boost Returns 



